BioInsights - Trends in academic ATMP development & manufacture in Europe

Trends in academic ATMP development & manufacture in Europe

Cell & Gene Therapy Insights 2022; 8(6), 725–729

DOI: 10.18609/cgti.2022.106

Published: 10 July 2022
Pauline Meij


Pauline Meij is the head of the Center for Cell and Gene therapy (CCG) at the Leiden University Medical Center (LUMC). She is responsible for the production of ATMPs at the LUMC, Qualified Person for ATMPs and she is actively involved in the clinical translation of ATMPs. The research focus of Pauline Meij is on the clinical translation of cell and gene therapy products, the regulation involved, patient access and the role of academia in this. She was the lead author of the LERU ATMP briefing paper. Pauline Meij is a member of the ATMP expert group of the Dutch Medicines Evaluation Board and member of the ATMP working party of The Netherlands and Flemish Belgium.